All In MedTech

FDA Clearance Tracker · P970004-S087

MODEL 3058 INTERSTIM 2 NEUROSTIMULATOR

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 9, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 9, 2011

Approved

Time to decision

289 days

Received Aug 24, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970004-S087
Device name
MODEL 3058 INTERSTIM 2 NEUROSTIMULATOR
Applicant location
Minneapolis, MN
Received
Aug 24, 2010
Decided
Jun 9, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P970004

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

APPROVAL FOR DESIGN AND SPECIFICATION CHANGES TO THE MODEL 3058 INTERSTIM II BATTERY.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.